News
This certification reflects the company's progress in climate and water efficiency, with outstanding performance in energy efficiency, emission reduction, and environmental policies.The company ...
A Cleveland Clinic-led clinical trial of tolebrutinib, an investigational oral Bruton's tyrosine kinase inhibitor, a group of drugs originally developed to treat lymphomas and related blood disorders, ...
EDT COPT Defense Properties (CDP) files automatic mixed securities shelfStay Ahead of the Market: Discover outperforming stocks and ...
Market Set for Explosive Growth, Projected to Reach $25.34 Billion by 2030 MIDDLETON, Mass., April 8, 2025 /PRNewswire/ -- QKS Group, a premier market intelligence ...
QKS Group, a premier market intelligence and advisory firm, has unveiled its latest comprehensive analysis of the global ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results